Menopause perspectives and treatment of Asian women

Seminars in Reproductive Medicine

Volumn 28, Issue 5, 2010, Pages 396-403

  Huang, Ko En ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Asian women; menopause; perspectives; symptoms; treatment

Indexed keywords

ANDROGEN; CLONIDINE; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; GABAPENTIN; PHYTOESTROGEN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TIBOLONE;

AGING; ASIAN; BREAST CANCER; CARDIOVASCULAR DISEASE; FEMALE; FEMALE SEXUAL DYSFUNCTION; HORMONE SUBSTITUTION; HUMAN; INSOMNIA; MENOPAUSAL SYNDROME; MENOPAUSE; MUSCULOSKELETAL DIAGNOSIS; OSTEOPOROSIS; REVIEW; SYMPTOMATOLOGY; VASOMOTOR DISORDER;

AGED; ASIA; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LIFE STYLE; MENOPAUSE; MIDDLE AGED; MUSCULOSKELETAL PHYSIOLOGICAL PHENOMENA; MUSCULOSKELETAL SYSTEM; NORPREGNENES; SLEEP INITIATION AND MAINTENANCE DISORDERS; WOMEN'S HEALTH;

EID: 77956969585     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0030-1262899     Document Type: Review

References (53)

1. Freeman E W., Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 2007 10 (3) 197-214
2. Ho S C., Chan S G., Yip Y B., Cheng A, Yi Q, Chan C. Menopausal symptoms and symptom clustering in Chinese women. Maturitas 1999 33 (3) 219-227
3. Pan H-A, Wu M-H, Hsu C C., Yao B L., Huang K E. The perception of menopause among women in Taiwan. Maturitas 2002 41 (4) 269-274
4. Chang C, Chang C H. Menopause and hormone using experiences of Chinese women in Taiwan. Health Care Women Int 1996 17 (4) 307-318
5. Chim H, Tan B HI, Ang C C., Chew E MD, Chong Y S., Saw S M. The prevalence of menopausal symptoms in a community in Singapore. Maturitas 2002 41 (4) 275-282
6. Tan D, Darmasetiawan S, Haines C J. et al, Expert Panel on Menopause in Asian Women. Guidelines for hormone replacement therapy of Asian women during the menopausal transition and thereafter. Climacteric 2006 9 (2) 146-151
7. Asia Pacific Menopause Federation. Asia-Pacific Menopause Federation consensus statement on the management of the menopause; April 2008. Available at: www.apmf.net Accessed June 3, 2010
8. Haines C J., Xing S M., Park K-H, Holinka C F., Ausmanas M K. Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated estrogens/ medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study. Maturitas 2005 52 (34) 264-276
9. Taechakraichana N, Holinka C F., Haines C J., Subramaniam R, Tian X W., Ausmanas M K. Distinct lipid/lipoprotein profiles and hormonal responsiveness in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study. Climacteric 2007 10 (3) 225-237
10. Limpaphayom K K., Darmasetiawan M S., Hussain R I., Burriss S W., Holinka C F., Ausmanas M K. Differential prevalence of quality-of-life categories (domains) in Asian women and changes after therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study. Climacteric 2006 9 (3) 204-214
11. Huang K-E, Xu L, I N N., Jaisamrarn U. The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function. Maturitas 2010 65 (3) 276-283
12. Genazzani A R., Schneider H P., Panay N, Nijland E A. The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy. Gynecol Endocrinol 2006 22 (7) 369-375
13. Huang K-E, Baber R. Updated clinical recommendations for the use of tibolone in Asian women. Climacteric 2010 May 5 (Epub ahead of print)
14. Haines C J., Rong L, Chung T KH, Leung D HY. The perception of the menopause and the climacteric among women in Hong Kong and southern China. Prev Med 1995 24 (3) 245-248
15. Lock M, Kaufert P, Gilbert P. Cultural construction of the menopausal syndrome: the Japanese case. Maturitas 1988 10 (4) 317-332
16. Obermeyer C M. Menopause across cultures: a review of the evidence. Menopause 2000 7 (3) 184-192
17. Sukwatana P, Meekhangvan J, Tamrongterakul T, Tanapat Y, Asavarait S, Boonjitrpimon P. Menopausal symptoms among Thai women in Bangkok. Maturitas 1991 13 (3) 217-228
18. Chaikittisilpa S, Limpaphayom K, Chompootweep S, Taechakraichana N. Symptoms and problems of menopausal women in Klong Toey slum. J Med Assoc Thai 1997 80 (4) 257-261
19. Zhao G, Wang L, Yan R, Dennerstein L. Menopausal symptoms: experience of Chinese women. Climacteric 2000 3 (2) 135-144
20. Punyahotra S, Dennerstein L, Lehert P. Menopausal experiences of Thai women. Part 1: Symptoms and their correlates. Maturitas 1997 26 (1) 1-7 (Pubitemid 27063774)
21. Wasti S, Robinson S C., Akhtar Y, Khan S, Badaruddin N. Characteristics of menopause in three socioeconomic urban groups in Karachi, Pakistan. Maturitas 1993 16 (1) 61-69
22. Rossouw J E., Anderson G L., Prentice R L. et al, Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002 288 (3) 321-333
23. Anderson G L., Limacher M, Assaf A R. et al, Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004 291 (14) 1701-1712
24. Naftolin F, Schneider H PG, Sturdee D W. et al, Executive Committee of the International Menopause Society. Guidelines for hormone treatment of women in the menopausal transition and beyond. Climacteric 2004 7 (4) 333-337
25. Skouby S O., Al-Azzawi F, Barlow D et al, European Menopause and Andropause Society. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy. Maturitas 2005 51 (1) 8-14
26. North American Menopause Society. Recommendations for estrogen and progestogen use in peri-and postmenopausal women: October 2004 position statement of the North American Menopause Society. Menopause 2004 11 (6 Pt 1) 589-600
27. Redactor G. Posición Latinamericana en relación con el estado actual de la terapia hormonal. Ginecol Obstet Mex 2005 73 205-211
28. Pines A, Sturdee D W., Birkhauser M H., Schneider H PG, Gambacciani M, Panay N, for the Board of the International Menopause Society. IMS updated recommendation on postmenopausal hormone therapy. Climacteric 2007 10 181-194
29. Utian W H., Shoupe D, Bachmann G, Pinkerton J V., Pickar J H. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 2001 75 (6) 1065-1079
30. Nijland E A., Weijmar Schultz W C., Nathorst-Boös J et al, LISA study investigators. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in natural menopausal women: results of a randomized active-controlled trial. J Sex Med 2008 5 646-656
31. Hammar M L., van de Weijer P, Franke H R., Pornel B, von Mauw E M., Nijland E A., Total Study Investigators Group. Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability. Br J Obstet Gynaecol 2007 114 1522-1529
32. Pan H A., Wang S T., Pai M C., Chen C H., Wu M H., Huang K E. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison. J Reprod Med 2003 48 (5) 375-380
33. Wu M H., Pan H A., Wang S T., Hsu C C., Chang F M., Huang K E. Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy. Climacteric 2001 4 (4) 314-319
34. Yang T S., Tsan S H., Chen C R., Chang S P., Yuan C C. Evaluation of conjugated estrogen plus medroxyprogesterone acetate versus tibolone in early postmenopausal Chinese women. Zhonghua Yi Xue Za Zhi (Taipei) 1999 62 (5) 308-315
35. Lam P M., Cheung G W., Shek D T., Lee D T., Haines C J., Chung T K. A randomized, placebo-controlled, crossover study of tibolone (Livial) on menopause symptoms, psychological well-being, and dyadic relationship of postmenopausal Chinese women and their spouses. Menopause 2004 11 (4) 416-422
36. Koh K K., Ahn J Y., Jin D K. et al. Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women: a randomized, double-blind, placebo-controlled, crossover study. Arterioscler Thromb Vasc Biol 2003 23 (10) 1889-1894
37. Lee K B., Lee J M., Yoon J H., Park C Y. The safety of tibolone in epithelial ovarian cancer patients. Maturitas 2006 55 (2) 156-161
38. Cummings S R., Ettinger B, Delmas P D. et al, LIFT Trial Investigators. The effects of tibolone in older postmenopausal women. N Engl J Med 2008 359 (7) 697-708
39. White R H., Keenan C R. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res 2009 123 (Suppl 4) S11-S17
40. Tan K S., Rashid A, Tan C T. Venous thromboembolism in ischemic stroke in Asia. Neurology Asia 2008 13 95-101
41. Valdivia I, Campodónico I, Tapia A, Capetillo M, Espinoza A, Lavn P. Effects of tibolone and continuous combined hormone therapy on mammographic breast density and breast histochemical markers in postmenopausal women. Fertil Steril 2004 81 (3) 617-623
42. Bruce D, Robinson J, McWilliams S, Reddy M, Fentiman I, Rymer J. Long-term effects of tibolone on mammographic density. Fertil Steril 2004 82 (5) 1343-1347
43. Krebs E E., Ensrud K E., MacDonald R, Wilt T J. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004 104 (4) 824-836
44. Geller S E., Studee L. Soy and red clover for mid-life and aging. Climacteric 2006 9 (4) 245-263
45. Liu H, Yang D N. Clinical observations on treatment of 86 peri-climacteric syndrome cases by point cutgut embedding. Shanghai J Acupunct Mox 2007 26 5-7
46. Zhou J, Qin Z Y., Li W L. et al. Clinical observation on therapeutic effect of electroacupuncture at Sanyinjiao (SP 6) on peri-menopausal syndrome [in Chinese]. Zhongguo Zhen Jiu 2006 26 (9) 617-620
47. Cho S-H, Whang W-W. Acupuncture for vasomotor menopausal symptoms: a systematic review. Menopause 2009 16 (5) 1065-1073
48. Chow L. Breast cancer incidence rising in Asian women at younger age: Sunitinib shows potential as treatment for metastatic disease. First Asian Breast Cancer Conference November 22, 2009 New Delhi, India
49. Chang K-J, Kuo W-H, Wang M-Y. The epidemiology of breast cancer in Taiwan [in Chinese with English abstract]. J Oncol Soc 2008 24 85-93
50. Ravdin P M., Cronin K A., Howlader N et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 2007 356 (16) 1670-1674
51. Greendale G A., Reboussin B A., Sie A et al, Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Ann Intern Med 1999 130 (4 Pt 1) 262-269
52. Habel L A., Capra A M., Oestreicher N et al. Mammographic density in a multiethnic cohort. Menopause 2007 14 (5) 891-899
53. Grodstein F, Manson J E., Stampfer M J. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt) 2006 15 (1) 35-44 (Pubitemid 43192860)